| Joseph Todisco |
Joseph Todisco is the founder of Gemini Laboratories LLC. He is currently the Chief Executive Officer & Director at CorMedix, Inc. since 2022. He is also currently the Vice President-Business Development & Licensing at Ranbaxy, Inc. Additionally, he holds the position of Chief Commercial Officer-Specialty & Executive VP at Amneal Intermediate, Inc. since 2020. Previously, he worked as the Senior Vice President-Global Strategy & Operations at Amneal Pharmaceuticals LLC. Mr. Todisco has an MBA from Fordham University and an undergraduate degree from Georgetown University. |
| Myron Lawrence Kaplan |
Myron Lawrence Kaplan's current jobs include Chairman at CorMedix, Inc., Vice Chairman at JBI International, Inc., Director at Children's Museum of Manhattan, Inc., Director at Liverpool Associates Ltd., Director at EALL LLC, and Founding Partner at Kleinberg, Kaplan, Wolff & Cohen PC. His former jobs include Director at Trans World Airlines, Inc., Director at Kitty Hawk, Inc., Director at SAirGroup Finance (USA), Inc., and Trustee at Lehman Brothers Holdings, Inc. He completed his undergraduate degree at Columbia College Corp. and his graduate degree at Harvard Law School. |
| Erin Mistry |
Erin Mistry is currently the Chief Commercial Officer & Senior Vice President at CorMedix, Inc. (since 2023). Prior to this, Mr. Mistry worked as the Vice President - Market Access at Intarcia Therapeutics, Inc. |
| Mathew T. David |
Mathew T. David is currently the Chief Financial Officer & Executive Vice President at CorMedix, Inc. He previously worked at Ovid Therapeutics, Inc. as the Head-Strategy. Dr. David completed his undergraduate degree at Dartmouth College and holds a doctorate from New York University School of Medicine. |
| Phoebe Mounts |
Phoebe Mounts is Executive Vice President for CorMedix, Inc.
Dr. Mounts previously held the position of Partner at Morgan, Lewis & Bockius LLP.
Dr. Mounts received a graduate degree from Georgetown University Law Center and a doctorate from The University of Edinburgh. |
| Elizabeth Masson-Hurlburt |
Elizabeth Masson-Hurlburt is currently the Chief Clinical Strategy & Operations Officer at CorMedix, Inc. Prior to her current position, she worked as the Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018. Ms. Masson-Hurlburt completed her undergraduate degree at Bay Path College. |
| Tushar Mukherjee |
Tushar Mukherjee currently works at CorMedix, Inc., as Senior Vice President-Technical Operations from 2023. |
| Steven W. Lefkowitz |
Steven W. Lefkowitz was the founder of Wade Capital Corp. founded in 1990, where he held the position of President & Director from 1990 to 2012. Currently, he is an Independent Director at CorMedix, Inc. since 2017 and a Director at AIS RE Ltd. since 2001. He was the Chairman of Medconx, Inc. from 2007 to 2015 and a Director at Franklin Credit Holding Corp. from 1996 to 2011. He was also a Director at CorMedix, Inc. from 2011 to 2016. Additionally, he served as an Independent Director at Franklin Credit Management Corp. from 1996 to 2015 and as an Independent Director at Specialty Liquid Transportation Corp. He was a Vice President-Corporate Finance at Drexel Burnham Lambert, Inc. Mr. Lefkowitz received his undergraduate degree from The Trustees of Columbia University in The City of New York and Dartmouth College in 1977. |
| Alan W. Dunton |
Alan W. Dunton founded Danerius LLC in 2006, where he worked as Principal from 2006 to 2015. Dr. Dunton also currently works at Palatin Technologies, Inc., as Independent Director from 2011, Oragenics, Inc., as Independent Director from 2011, ActivBiotics, Inc., as Director from 2007, and various other companies. Dr. Dunton also formerly worked at Metaphore Pharmaceuticals, Inc., as President & Chief Executive Officer from 2003 to 2006, Janssen-Cilag International NV, as Chairman, EpiCept Corp., as Non-Executive Chairman from 2012 to 2013, and various other companies. Dr. Dunton received his undergraduate degree from State University of New York at Buffalo and doctorate degree in 1980 from New York University School of Medicine. |
| Andrew Robert John Bonfield |
Andrew Robert John Bonfield is currently the Chairman of The Hundred Group of Finance Directors, a Director at Caterpillar Financial Services Corp., a Director at National Grid Holdings Ltd., the Chief Financial Officer at Caterpillar, Inc., and an Independent Non-Executive Director at Reckitt Benckiser Group Plc. In the past, he was the Director at ImClone LLC, Finance Director at BG Group Ltd., Executive Director & Finance Director at National Grid Plc, Independent Non-Executive Director at Kingfisher plc, Director at National Grid Holdings One Plc, Director at National Grid (US) Holdings Ltd., Chief Financial Officer & Executive Vice President at Bristol Myers Squibb Co., Chief Financial Officer at Smithkline Beecham Plc, and Chief Financial Officer at Cadbury Ltd. He received his undergraduate degree from the University of Natal. |
| Robert A. Stewart |
Robert A. Stewart currently holds multiple CEO positions at Theramex HQ UK Ltd., Theramex Italy Srl, and is a Vice Chairman at the Association for Accessible Medicines. He is also an Independent Director at CorMedix, Inc. and an Independent Non-Executive Director at Cipla Ltd. Additionally, he serves as a Director at IWH UK Midco Ltd., IWH UK Finco Ltd., IWH UK Investco Ltd., and IWH UK Holdco Ltd. He is a Trustee at Fairleigh Dickinson University and was previously the President-Global Operations at Anda, Inc. His former positions include President & Chief Executive Officer at Amneal Pharmaceuticals LLC, President, Chief Executive Officer & Director at Amneal Intermediate, Inc., Vice President-Global Supply Chain at Abbott Laboratories, Chief Operating Officer at Forest Laboratories, Inc., President-Global Operations at Actavis, Inc., and Principal at Hoffmann-La Roche, Inc. He also held a Principal position at Knoll Pharmaceutical Co. and was the Chief Operating Officer & Executive Vice President at Allergan Ltd. (Ireland). He received his undergraduate degree from Fairleigh Dickinson University in 1994. |
| Janet D. Dillione |
Janet D. Dillione is currently the Chief Executive Officer at Connect America.com LLC since 2020. She is also the Chief Executive Officer at Bernoulli Enterprise, Inc. since 2014. Additionally, she serves as an Independent Director at CorMedix, Inc. since 2015. Ms. Dillione is a Director at Vizient, Inc. and a Director at CortiCare, Inc. Ms. Dillione previously held the position of Chief Executive Officer at Cardiopulmonary Corp. and Contact America. From 2000 to 2010, she was the President & CEO-Global Healthcare IT Division at Siemens Medical Solutions USA, Inc. From 2010 to 2014, she served as the Executive Vice President & GM-Healthcare Division at Nuance Communications, Inc.Ms. Dillione completed her undergraduate degree at Brown University in 1981. |
| Gregory Duncan |
Gregory Duncan is currently the Chairman & Chief Executive Officer at Virios Therapeutics, Inc. He is also an Independent Director at CorMedix, Inc. and a Director at Biotechnology Innovation Organization, Center for Global Health Innovation, Inc., Southeast BIO, American Psychiatric Foundation, and Biotie Therapeutics Corp. Previously, he was the President, Chief Executive Officer & Director at Celtaxsys, Inc. from 2014 to 2020. He was also the President-Latin America Operations & Senior VP at Pfizer Inc. from 1989 to 2007 and the Executive VP & President-North America Operations at UCB SA from 2012 to 2013. He holds an MBA from Emory University and an undergraduate degree from State University of New York at Albany. |
